Literature DB >> 27473801

Laparoscopic Roux-en-Y Gastric Bypass: Surgical Technique and Perioperative Care.

Lindsay Berbiglia1, John G Zografakis2, Adrian G Dan3.   

Abstract

Obesity is a global epidemic with multiple associated comorbid conditions. The laparoscopic Roux-en-Y gastric bypass is the gold standard operation in the fight against obesity. This review outlines the common technical aspects of the procedure, as well as the evidence based recommendations for preoperative and postoperative care.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbid conditions; Laparoscopic Roux-en-Y gastric bypass; Obesity

Mesh：

Year:  2016        PMID： 27473801     DOI： 10.1016/j.suc.2016.03.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  4 in total

1.  Randomized, Double-Blind Study of the Effect of Intraoperative Intravenous Lidocaine on the Opioid Consumption and Criteria for Hospital Discharge After Bariatric Surgery.

Authors:  Rioko K Sakata; Roclides C de Lima; Jose A Valadão; Plinio C Leal; Ed Cr Moura; Vitor P Cruz; Caio Mb de Oliveira
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Proximal Roux-en-Y gastric bypass: Addressing the myth of limb length.

Authors:  Bestoun Ahmed; Wendy C King; William Gourash; Amanda Hinerman; Steven H Belle; Alfons Pomp; Walter J Pories; Anita P Courcoulas
Journal:  Surgery       Date:  2019-08-01       Impact factor: 3.982

3.  Laparoscopic Roux-en-Y Gastric Bypass Without Division of the Mesentery Reduces the Risk of Postoperative Complications.

Authors:  Olof Backman; Jacob Freedman; Richard Marsk; Henrik Nilsson
Journal:  Surg Endosc       Date:  2018-11-20       Impact factor: 4.584

4.  Effects of short or long biliopancreatic limb length after laparoscopic Roux-en-Y gastric bypass surgery for obesity: a propensity score-matched analysis.

Authors:  Christoph Eckharter; Nickolaus Heeren; Francesco Mongelli; Martin Sykora; Hartwig Fenner; Andreas Scheiwiller; Jürg Metzger; Jörn-Markus Gass
Journal:  Langenbecks Arch Surg       Date:  2022-05-10       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.